|Free Dividend Report|
|Stock Splits Calendar|
|ACRX Historical Stock Prices|
|Preferred Stock Newsletter|
|ACRX Options Chain|
|ACRX Message Board|
AcelRx Pharmaceuticals (ACRX) has the following price history information. Looking back at ACRX historical stock prices for the last five trading days, on November 22, 2023, ACRX opened at $0.62, traded as high as $0.65 and as low as $0.61, and closed at $0.64. Trading volume was a total of 117.90K shares. On November 24, 2023, ACRX opened at $0.62, traded as high as $0.69 and as low as $0.61, and closed at $0.69. Trading volume was a total of 71.70K shares. On November 27, 2023, ACRX opened at $0.70, traded as high as $0.78 and as low as $0.66, and closed at $0.74. Trading volume was a total of 255.80K shares. On November 28, 2023, ACRX opened at $0.74, traded as high as $0.80 and as low as $0.67, and closed at $0.72. Trading volume was a total of 157.00K shares. On November 29, 2023, ACRX opened at $0.70, traded as high as $0.71 and as low as $0.67, and closed at $0.69. Trading volume was a total of 148.30K shares.
ACRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AcelRx Pharmaceuticals shares, starting with a $10,000 purchase of ACRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-43.26%|
|ACRX Historical Price Range|
|About AcelRx Pharmaceuticals|
|AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. Co.'s nafamostat product candidates include Niyad, which is being developed as a regional anticoagulant for injection into the extracorporeal circuit; and LTX-608, which is Co.'s proprietary nafamostat formulation for direct IV infusion. Co.'s pre-filled syringe product candidates include Fedsyra, which is an ephedrine pre-filled syringe; and the phenylephrine pre-filled syringe.|
|ACRX Historical Closing Prices|
|Healthcare Historical Prices|
|ACRX is categorized under the Healthcare sector; below are some other companies in the same sector:
ACST Historical Stock Prices
Also explore: ACRX shares outstanding history
ACRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.